ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 36902170

DNA Damage and Its Role in Cancer Therapeutics.

Moon J and 5 others. Int J Mol Sci, 2023. Cited by 63 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. DNA Damage and Its Role in Cancer Therapeutics. Papers, record 36902170. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36902170

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
DNA Damage and Its Role in Cancer Therapeutics.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
63
iCite
Relative citation ratio, by iCite
6.2
iCite
Revised in PubMed
2024-09-14
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Moon JJaeyoung
2Kitty IIchiwa
3Renata KKusuma
4Qin SSisi
5Zhao FFei
6Kim WWootaehttps://orcid.org/0000-0003-4364-3260

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DNA DamageMajor topic
DNA RepairMajor topic
NeoplasmsMajor topic
Humans
BRCA1 Protein
Mutation
BRCA2 Protein

Source PubMed

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
NRF-2022R1A2C1091563National Research Foundation of KoreaPubMed
NRF- 2019M3E5D3073092National Research Foundation of KoreaPubMed
NRF- 2019R1A5A8083404National Research Foundation of KoreaPubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References142

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132,991,949Reality CHEK: Understanding the biology and clinical potential of CHK1.Cancer Lett2021https://conductscience.org/library/papers/32991949PubMed
226,437,586Repair Pathway Choices and Consequences at the Double-Strand Break.Trends Cell Biol2016https://conductscience.org/library/papers/26437586PubMed
327,555,866DNA Damage Response and Immune Defense: Links and Mechanisms.Front Genet2016https://conductscience.org/library/papers/27555866PubMed
420,713,514Expanded roles of the Fanconi anemia pathway in preserving genomic stability.Genes Dev2010https://conductscience.org/library/papers/20713514PubMed
527,264,557DNA polymerase θ (POLQ), double-strand break repair, and cancer.DNA Repair (Amst)2016https://conductscience.org/library/papers/27264557PubMed
620,192,759The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway.Annu Rev Biochem2010https://conductscience.org/library/papers/20192759PubMed
720,177,395Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis.Nat Rev Mol Cell Biol2010https://conductscience.org/library/papers/20177395PubMed
818,431,258DNA damage and repair: relevance to mechanisms of neurodegeneration.J Neuropathol Exp Neurol2008https://conductscience.org/library/papers/18431258PubMed
916,571,728Cernunnos interacts with the XRCC4 x DNA-ligase IV complex and is homologous to the yeast nonhomologous end-joining factor Nej1.J Biol Chem2006https://conductscience.org/library/papers/16571728PubMed
1032,226,530Copy Number Amplification of DNA Damage Repair Pathways Potentiates Therapeutic Resistance in Cancer.Theranostics2020https://conductscience.org/library/papers/32226530PubMed

1 to 10 of 142

See all 142 references

Cited by46

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.

PMIDTitleJournalYearIn PapersSource
42,941,816In Vitro Anti-Proliferative and Cisplatin-Modulating Effects of Cedrus libani A. Rich Leaf Essential Oil on H460 and HT-29 Human Cancer Cell Lines.Int J Mol Sci2026https://conductscience.org/library/papers/42941816PubMed
42,706,241Nuclear localization of the glutaminyl-tRNA synthetase QARS reveals its role in DNA damage response in ovarian cancer.Nat Commun2026https://conductscience.org/library/papers/42706241PubMed
42,649,359Impact of combined acidic and oxidative stress on guanine DNA damage.Sci Rep2026https://conductscience.org/library/papers/42649359PubMed
42,640,499The potential of harmaline on triple negative breast cancer: harmaline-DNA interaction related apoptosis, anti-metastasis, and in silico analysis.Histochem Cell Biol2026https://conductscience.org/library/papers/42640499PubMed
42,472,416A Spatiotemporal Image-Guided Model of Radiopharmaceutical Transport in Heterogeneous Vasculature Prostate Tumor: A Computational Analysis of Key Parameters in Lutetium-177 PSMA Therapy.Ann Biomed Eng2026https://conductscience.org/library/papers/42472416PubMed
42,353,047TPI and GAPDH Interact with Rad9, Linking Glycolytic Enzymes to Cancer.Int J Mol Sci2026https://conductscience.org/library/papers/42353047PubMed
42,352,527Breaking the Balance: Baseline Oxidative Stress and DNA Repair Capacity in Multiple Myeloma Therapy.Cancers (Basel)2026https://conductscience.org/library/papers/42352527PubMed
42,237,147Not just splitting hairs-monitoring environmental chemical exposures, their biological effects and their social determinants with hair shafts and follicles: a narrative review.Environ Health2026https://conductscience.org/library/papers/42237147PubMed
42,099,692Ruthenium(ii) polypyridyl complexes and the DNA damage response: mechanisms and therapeutic implications.RSC Med Chem2026https://conductscience.org/library/papers/42099692PubMed
41,923,137Targeting cell death: a promising approach for colorectal cancer therapy.Cancer Cell Int2026https://conductscience.org/library/papers/41923137PubMed

1 to 10 of 46

See all 46 cited by

Genes53

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APEX1328PubTator's text mininghttps://conductscience.org/library/genes/328NCBI Gene
ASTE128,990PubTator's text mininghttps://conductscience.org/library/genes/28990NCBI Gene
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
ATMIN23,300PubTator's text mininghttps://conductscience.org/library/genes/23300NCBI Gene
ATR545PubTator's text mininghttps://conductscience.org/library/genes/545NCBI Gene
ATRIP84,126PubTator's text mininghttps://conductscience.org/library/genes/84126NCBI Gene
BARD1580PubTator's text mininghttps://conductscience.org/library/genes/580NCBI Gene
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
BRCA2675PubTator's text mininghttps://conductscience.org/library/genes/675NCBI Gene
BRD729,117PubTator's text mininghttps://conductscience.org/library/genes/29117NCBI Gene

1 to 10 of 53

See all 53 genes

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36902170

GET https://conductscience.org/api/papers/v1/36902170/references?page=2

API referenceFor AI assistants